209 related articles for article (PubMed ID: 8179848)
1. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
Lacourcière Y; Lefebvre J; Poirier L; Archambault F; Arnott W
Am J Hypertens; 1994 Feb; 7(2):137-45. PubMed ID: 8179848
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
Lacourcière Y; Arnott W
J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
5. [Experience of the use of nebivolol in the treatment of hypertension in postmenopausal women].
Bart BIa; Benevskaia VF; Buval'tsev VI; Boronenkov GM
Kardiologiia; 2002; 42(8):20-4. PubMed ID: 12494089
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
Grassi G; Seravalle G; Brambilla G; Dell'Oro R; Trevano FQ; Fici F; van Bortel L; Mancia G
Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
[TBL] [Abstract][Full Text] [Related]
8. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
9. Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life.
Van Bortel LM; Breed JG; Joosten J; Kragten JA; Lustermans FA; Mooij JM
J Cardiovasc Pharmacol; 1993 Jun; 21(6):856-62. PubMed ID: 7687708
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol/hydrochlorothiazide (HCTZ) combination in patients with essential hypertension: a pooled analysis from five non-interventional studies with a focus on diabetic and elderly patients.
Malacco E
Eur Rev Med Pharmacol Sci; 2010 May; 14(5):427-34. PubMed ID: 20556921
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.
Weiss RJ; Saunders E; Greathouse M
Clin Ther; 2011 Sep; 33(9):1150-61. PubMed ID: 21864908
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
[TBL] [Abstract][Full Text] [Related]
13. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Lacourcière Y; Lefebvre J; Provencher P; Poirier L
Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
Lewin A; Punzi H; Luo X; Stapff M
Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
[TBL] [Abstract][Full Text] [Related]
15. Nebivolol in the management of essential hypertension: a review.
McNeely W; Goa KL
Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
Punzi H; Lewin A; Lukić T; Goodin T; Wei Chen
Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):349-57. PubMed ID: 21088095
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
Papademetriou V
Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of antihypertensive efficacy of DL-nebivolol and D-nebivolol in patients with confirmed mild to moderate hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J
J Cardiovasc Pharmacol; 1995 Apr; 25(4):619-24. PubMed ID: 7596131
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
Rosei EA; Rizzoni D; Comini S; Boari G;
Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
